Jakarta, Nov. 25 -- Bio Farma is ready to produce five million doses of the IndoVac vaccine by 2022-end to support the second booster vaccinations for the elderly, president director of the state-owned pharmaceutical company, Honesti Basyir, has informed.

"We will prepare the IndoVac vaccine for booster vaccination of the elderly group. The production process has been underway since the issuance of the Emergency Use Authorization (EUA) for primary doses at the end of September 2022," Basyir said in a press statement received here on Friday.

In its circular letter Number HK.02.02/C/5565/2022 concerning the second booster dose of the COVID-19 vaccination for the elderly group, issued on November 22, 2022, the Health Ministry said that the...